Rapamycin shows promise in slowing Alzheimer's disease progression linked to seizures

Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer's disease (AD) who also experience seizures demonstrate more rapid cognitive decline than those who do not experience seizures.

Related Keywords

Francese Jensen ,Aaron Barbour ,University Of Pennsylvania School Medicine ,Alzheimer Association ,National Institutes Of Health ,Penn Department Of Neurology ,University Of Pennsylvania Perelman School Medicine ,Pennsylvania School ,Perelman School ,National Institutes ,Transplant ,Lzheimer 39s Disease ,Rain ,Brain Cell ,Fell ,Ognitive Function ,Epilepsy ,Hospital ,Medicine ,Eurology ,Eurons ,Protein ,Rapamycin ,Research ,Seizure ,